Skip to main content

Craniopharyngioma clinical trials at UCSF

1 research study open to eligible people

Craniopharyngioma is a rare type of brain tumor. UCSF is studying the use of two drugs, Nivolumab and DAY101, in treating this condition in children and young adults. The focus of this study is to see how well these drugs work together and how safe they are.

Showing trials for

Our lead scientists for Craniopharyngioma research studies include .

Last updated: